Sayana, Injektionssuspension (104 mg/0.65 ml)
7680620740017
CH-62074
Injektionssuspension
Associated product:
SAYANA susp inj 104 mg/0.65ml ser us unique
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Spritze(n)
- Galenic form
- Injektionssuspension
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
medroxyprogesteroni acetas
|
104.0 MG | Substance | Wirkstoff (Principe actif) |
|
natrii chloridum
|
- | Substance | HNIDK |
|
macrogolum 3350
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
natrii dihydrogenophosphas monohydricus
|
- | Substance | HNIDK |
|
dinatrii phosphas dodecahydricus
|
- | Substance | HNIDK |
|
povidonum K 17
|
- | Substance | HNIDK |
|
methioninum
|
- | Substance | HNIDK |
|
propylis parahydroxybenzoas
|
0.1 MG | Substance | HBESI |
|
E 218
|
1.04 MG | Substance | HBESI |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
2.158 MG | Substance | HBESI |
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 62074
- Drug name
- Sayana, Injektionssuspension
- Galenic form
- SUPA
- ATC Code
- G03AC06
- Authorization status
- Revoked/Withdrawn
- Dispensing category
- B
- First authorization
- 05/04/2012
- Authorization expiration date
- 30/09/2025
- IT Number
- 09.02.1.
- Domain
- Human medicine
Package details
- Description (FR)
- SAYANA susp inj 104 mg/0.65ml ser us unique
- Description (DE)
- SAYANA Inj Susp 104 mg/0.65ml Einwegspr
- Market launch
- 05/04/2012
- Market withdrawal
- 30/09/2025
- Narcotic (BTM)
- No